Atento SA (ATTO) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Oct 6Oct 9Oct 14Oct 19Oct 22Oct 27Oct 30Nov 4

Key dataNov 4, 2026

Open$15.35

From 52W high−41.97%

Volume80612.00

Market cap$676.86M

P/E (TTM)—

P/S (TTM)501.4x

Div yield—

Key dataNov 4, 2026

Open

$15.35

From 52W high

−41.97%

Volume

80612.00

Market cap

$676.86M

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−12.4x

P/E (TTM)

—

RSI (14)

40.1

MomentumView details →

1D Return

−2.90%

YTD Return

—

ValuationView details →

P/E (Fwd)

—

P/E (TTM)

—

EV/EBITDA

−12.4x

EV/Sales

610.6x

P/S (TTM)

501.4x

P/B (TTM)

6.0x

ProfitabilityView details →

Gross Margin

40.44%

Net Margin

−4490.89%

EBITDA Margin

−4915.19%

ROE (TTM)

−53.76%

ROA (TTM)

−47.24%

Asset Turnover

0.01x

GrowthView details →

Revenue YoY

—

EPS YoY

—

FCF YoY

—

Revenue CAGR 3Y

—

EPS CAGR 3Y

−35.24%

EBITDA YoY

—

MomentumView details →

1D Return

−2.90%

YTD Return

—

1Y Return

—

RSI (14)

40.1

vs 50D SMA

−20.61%

vs 200D SMA

—

Capital & dividendView details →

Debt/Equity

0.04x

Current Ratio

9.39x

Quick Ratio

9.39x

Div Yield

—

Div Rate

—

Div Growth 1Y

—

EarningsView details →

EPS (Actual)

−$4.88

EPS Surprise

−655.53%

Beats (12Q)

0/12

Next Q EPS Est

−$0.49

Avg Surprise (4Q)

−655.53%

Rev Surprise

42.11%

Financials snapshotView financials →

Revenue (TTM)

450000.00

Net Income (TTM)

−68.93M

Op. CF (TTM)

−61.63M

Next earningsDec 2, 2026 →

Latest newsMore news →

No recent news for ATTO.

Similar companies

Candel Therapeutics, Inc.CADL SL Science Holding Limited Ordinary SharesSLBT 4D Molecular Therapeutics, Inc.FDMT Aura Biosciences, Inc.AURA Lexicon Pharmaceuticals, Inc.LXRX Solid Biosciences Inc.SLDB Find similar companies →

Latest newsMore news →

No recent news for ATTO.